Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn's disease who are starting adalimumab.
Source: medscape.com
Stay updated with breaking news from Improvecarenow Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn's disease who are starting adalimumab.